Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
ACET Adicet Bio
- 0.960
- -0.022-2.24%
Close Jan 8 16:00 ET
- 0.954
- -0.006-0.57%
Post 20:01 ET
79.10MMarket Cap-0.56P/E (TTM)
0.990High0.921Low464.17KVolume0.988Open0.982Pre Close441.29KTurnover0.75%Turnover RatioLossP/E (Static)82.40MShares3.62052wk High0.37P/B59.61MFloat Cap0.81052wk Low--Dividend TTM62.10MShs Float214.348Historical High--Div YieldTTM7.00%Amplitude0.810Historical Low0.950Avg Price1Lot Size
About Adicet Bio Company
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Company Profile
SymbolACET
Company NameAdicet Bio
Listing DateJan 26, 2018
Issue Price15.00
Founded2014
CEOMr. Chen Schor, M.B.A.
MarketNASDAQ
Employees143
Fiscal Year Ends12-31
Address131 Dartmouth Street,3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116
Phone1-650-503-9095
Websitehttp://www.adicetbio.com
Company Executives
- Name
- Position
- Salary
- Chen Schor, M.B.A.
- Chief Executive Officer, President and Director
- --
- Dr. Francesco Galimi, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Donald Healey, PhD
- Chief Technology Officer
- --
- Dr. Blake Aftab, PhD
- Chief Scientific Officer
- --
- Nick Harvey
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Jeffrey A. Chodakewitz, M.D.
- Independent Director
- --
- Dr. Lloyd Klickstein, M.D.,PhD
- Independent Director
- --
- Steve Dubin, J.D.
- Independent Director
- --
- Dr. Aya Jakobovits, PhD
- Independent Director
- --
- Katie Peng
- Independent Director
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- --
- Dr. Andrew Sinclair, PhD
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.